Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination.
about
Neuropathology and animal models of autism: genetic and environmental factorsAltered synaptic plasticity in a mouse model of fragile X mental retardationWhat can we learn about autism from studying fragile X syndrome?Temporal requirements of the fragile X mental retardation protein in the regulation of synaptic structureInhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice.Targeting fragile X.SynCAM 1 adhesion dynamically regulates synapse number and impacts plasticity and learning.Super resolution microscopy is poised to reveal new insights into the formation and maturation of dendritic spinesSynaptic Plasticity, a Prominent Contributor to the Anxiety in Fragile X SyndromeMouse Genetic Models of Human Brain DisordersIn Sickness and in Health: Perineuronal Nets and Synaptic Plasticity in Psychiatric DisordersNon-muscle myosin II in disease: mechanisms and therapeutic opportunitiesCharacterizing autism spectrum disorders by key biochemical pathways.Modulation of actin dynamics by Rac1 to target cognitive functionAutism spectrum disorders and neuropathology of the cerebellumFragile X syndrome and targeted treatment trials.Dendritic spine dysgenesis in autism related disordersModeling neurological disorders by human induced pluripotent stem cellsBehavioral and Neuroanatomical Phenotypes in Mouse Models of AutismFragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice.A murine model of variant late infantile ceroid lipofuscinosis recapitulates behavioral and pathological phenotypes of human diseaseActinin-4 Governs Dendritic Spine Dynamics and Promotes Their Remodeling by Metabotropic Glutamate Receptors.Structural-functional connectivity deficits of neocortical circuits in the Fmr1 (-/y) mouse model of autism.Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and BackReview of targeted treatments in fragile X syndromeFragile X mental retardation protein: A paradigm for translational control by RNA-binding proteinsCommon mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disordersDeveloping and applying the adverse outcome pathway concept for understanding and predicting neurotoxicityNeuronal connectivity as a convergent target of gene × environment interactions that confer risk for Autism Spectrum DisordersMultiple EphB receptor tyrosine kinases shape dendritic spines in the hippocampusRegulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132Synaptically released matrix metalloproteinase activity in control of structural plasticity and the cell surface distribution of GluA1-AMPA receptorsTransport of fragile X mental retardation protein via granules in neurites of PC12 cells.The FXG: a presynaptic fragile X granule expressed in a subset of developing brain circuitsRescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486.A dual comparative approach: integrating lines of evidence from human evolutionary neuroanatomy and neurodevelopmental disordersDNA methylation: a mechanism linking environmental chemical exposures to risk of autism spectrum disorders?CYFIP1 coordinates mRNA translation and cytoskeleton remodeling to ensure proper dendritic spine formationDendritic spine pathology in neuropsychiatric disordersEnhanced expression of ADCY1 underlies aberrant neuronal signalling and behaviour in a syndromic autism model.
P2860
Q21284779-0A2E9938-0E39-4402-B913-F6D3EFA420E8Q24530695-BCE28095-5BC5-4B41-A864-928FC9B4C363Q24613049-B120FBD3-1F0A-4059-A7C3-03D069B1B9F5Q24645505-DEFC779B-4994-4BE1-962A-D822C32A879AQ24684102-37DE6D9A-DE69-4A9E-964D-6975077F6C38Q24791894-FFBC35DC-12C3-4BCD-A512-7D163CF56A2BQ26269902-0D48ECB7-9A12-4C7C-A766-17C60522083EQ26740700-D1846DAC-049C-40DA-9455-96B8BC9D1010Q26745117-5434D90C-7C5E-41C4-8806-B713F1914B39Q26752246-D9D50E33-EE2A-46B3-8236-26FB93935EEDQ26769948-93ECE17E-6D14-485B-A1B9-A0CFEF3FA46CQ26778962-418824C9-551B-41EB-8E62-19BBA106EEE3Q26781645-FDF7D7C3-6F92-4C67-B2D4-21675287546FQ26820813-45159208-DC88-4514-8F28-8CA4DC534F59Q26853603-00FEB985-1FE4-4D43-B457-850F776A4E7DQ26865162-D89C0A9B-47A2-4457-8BE0-84BEFDD7D1CAQ26995242-E87DC8AA-1370-47A7-8C8C-173AA69EF212Q27011777-BC458013-DCCC-4E40-A38B-49F27E90F47FQ27025227-B013A478-483B-4553-A909-A8755EB84198Q27301086-5445EAE7-6BCF-4675-B3AD-DF6469F3D3C4Q27303003-2133BD88-E5B9-4B95-8023-34B7FE02C412Q27313315-8679E1A1-B290-4F77-8DD6-148DEB537DF6Q27336359-239D8DA1-C88D-49BD-851A-C09634DA8903Q27337360-EFCB58A5-3CF6-48F8-9FA5-06F18B25A4AAQ28077180-A4E00927-57A8-4C7A-A08B-401E48F620F9Q28086823-692BE92B-DB51-4250-B412-2D8B130E36C9Q28086869-A35B21E3-F1CE-4C97-9744-5DFE14921483Q28394433-C93CCD45-40EB-4958-A26E-9F43F0397C9AQ28396205-E0282BD5-5A26-4088-A221-C27F2CE1C1E8Q28504623-34346A28-9B06-4F71-BA0B-6734F4A0CEAEQ28510360-8AB2E799-7FAF-4A20-9F02-5DFCD6A13186Q28539061-AF4AF1A6-9FD5-435C-853C-A5304F0ECB9FQ28574173-08AF6207-4DBE-4C0C-9080-9E8986FDC01FQ28588310-4731945E-C4B8-42B5-B315-03058209C543Q28593254-685D797D-D77F-4187-B93D-21AF8E0CF652Q28655504-CCC334EF-6CE9-4C0F-9988-244B2C036314Q28833595-767A2056-2EB4-4B1E-BC69-2BD36ACB754EQ28910185-D4599591-D90C-4543-897A-94FA9A4D048EQ29615871-3B51983A-C758-4931-BC6B-8EB3628C69EEQ30362378-4E6BC29D-D4E3-469C-9828-3E2A5FF19F1B
P2860
Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Abnormal dendritic spine chara ...... e: a quantitative examination.
@ast
Abnormal dendritic spine chara ...... e: a quantitative examination.
@en
type
label
Abnormal dendritic spine chara ...... e: a quantitative examination.
@ast
Abnormal dendritic spine chara ...... e: a quantitative examination.
@en
prefLabel
Abnormal dendritic spine chara ...... e: a quantitative examination.
@ast
Abnormal dendritic spine chara ...... e: a quantitative examination.
@en
P2093
P2860
P1476
Abnormal dendritic spine chara ...... me: a quantitative examination
@en
P2093
B P Larsen
I J Weiler
J B Harris
M Idupulapati
P B Kozlowski
P J Willems
R A Crisostomo
P2860
P304
P356
10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B
P50
P577
2001-01-01T00:00:00Z